SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-003900
Filing Date
2020-03-13
Accepted
2020-03-13 16:10:42
Documents
80
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 514107
2 ex31-1.htm EX-31.1 19731
3 ex31-2.htm EX-31.2 18066
4 ex32-1.htm EX-32.1 6485
5 ex32-2.htm EX-32.2 6513
6 image_013.jpg GRAPHIC 25271
7 image_014.jpg GRAPHIC 2199
  Complete submission text file 0001493152-20-003900.txt   3322024

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE adxs-20200131.xml EX-101.INS 526078
9 XBRL SCHEMA FILE adxs-20200131.xsd EX-101.SCH 46784
10 XBRL CALCULATION FILE adxs-20200131_cal.xml EX-101.CAL 74517
11 XBRL DEFINITION FILE adxs-20200131_def.xml EX-101.DEF 122557
12 XBRL LABEL FILE adxs-20200131_lab.xml EX-101.LAB 313786
13 XBRL PRESENTATION FILE adxs-20200131_pre.xml EX-101.PRE 244842
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 20712764
SIC: 2834 Pharmaceutical Preparations